In the present study, the use of deep NGS in a large representative cohort of MM at diagnosis and more aggressive disease stages substantially confirmed the accepted notion that TP53 mutations in MM at presentation are rarely detected, while their frequency increases with disease progression. The gene discussed is TP53; the disease is Miyoshi myopathy.